Back

Med-IQ

  • Anti-Arrhythmia Agents
  • Atrial Fibrillation
  • Catheter Ablation
  • Wearable Electronic Devices

Addressing Increased Detection, Early Rhythm Control, and the Role of AADs in the Management of Contemporary AF

This activity focuses on the role of wearable devices in the timely identification of atrial fibrillation (AF) and the evolving evidence around the rationale for and efficacy/safety of early rhythm control strategies, including guideline recommendations and expert insights on the use of antiarrhythmic drugs (AADs) and catheter ablation.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1 credit

MOC types

ABS — Accredited CMEUp to 1 point

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 1 credit
  • MOC · Up to 1 point
  • Commercial Support
  • Released
    Mar 30, 2026
  • Last day to claim credit
    Mar 30, 2027 6 months left